Last updated: March 25, 2024
Sponsor: Riphah International University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism
Williams Syndrome
Asperger's Disorder
Treatment
conventional treatment
experimental treatment
Clinical Study ID
NCT06340139
Riphah/RCRAHS-ISB/REC/01742
Ages 13-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 13-18 years
- Both male and female
- Diagnosed Autism Spectrum disorder.
- Visual and/or Vestibular stimming diagnosed by physician.
Exclusion
Exclusion Criteria:
- Patients diagnosed with other neurological diseases
- Tumors or neoplasms
- Visual and auditory impairments
- Inability to respond to verbal command through verbal or non-verbal communicationcues.
Study Design
Total Participants: 44
Treatment Group(s): 2
Primary Treatment: conventional treatment
Phase:
Study Start date:
March 20, 2024
Estimated Completion Date:
August 20, 2024
Study Description
Connect with a study center
zamam autism Centre
Islamabad,
PakistanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.